Drug
Bg505 Sosip 664 Gp140
Bg505 Sosip 664 Gp140: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| BG505 SOSIP.664 gp140 NCT04177355 | Phase 1 | HIV Infections |
Latest
No recent events.
Follow Bg505 Sosip 664 Gp140 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.